Selected for NEDO's R&D-type Startup Support Program / Commercialization Support for Seed-Stage R&D-type Startups

iMed Technologies, Inc. (headquartered in Shibuya-ku, Tokyo; Representative Director and CEO, Kenichi Kono; hereafter “the Company”), which develops surgical support AI for endovascular surgery, has been selected for the fiscal 2020 “R&D-type Startup Support Program / Commercialization Support for Seed-Stage R&D-type Startups” (maximum grant: 70 million yen; hereafter “NEDO STS Program”) by the New Energy and Industrial Technology Development Organization (hereafter “NEDO”).

■NEDO STS Program implementation structure

• Recipient: iMed Technologies, Inc.
• Project name: Commercialization of surgical support AI to improve the safety of endovascular surgery
• Certified VC: SBI Investment Co., Ltd.

■iMed Technologies, Inc. Company Profile Company name: iMed Technologies, Inc. Address: 5F Eclat Shibuya, 3-6-2 Shibuya, Shibuya-ku, Tokyo Founded: April 1, 2019 Business: Development of surgical support AI for endovascular surgery Representative: Representative Director and CEO, physician Kenichi Kono

■Inquiries regarding this release Email: info@imed-tech.co.jp